Category Archives: News & updates

ABILIFY: Generic name Aripiprazole Antipsychotic second generation Indications Schizophrenia, Bipolar Disorder Dosage forms 2mg, 5 mg, 10mg, 15mg, 20mg, 30 mg Maximum daily dose Adults 30 mg Children 30 mg 10-17 yrs old Half life 75 Hours Side effects Nausea, … Continue reading →

I experienced an interesting confluence of events the other day. My 11-year-old son has been finding out about the great power of online information. Although we limit his access to assistance with homework, he is already a digital whiz kid … Continue reading →

Bipolar disorder causes havoc in patients’ lives. Even in the best of circumstances, successful treatment is challenging. Treatment targets constantly shift; patients are frequently nonadherent; and comorbidity is the rule, not the exception. Diagnosis of bipolar disorder is often difficult. … Continue reading →

Astute readers of obituaries know that “died unexpectedly” is a common euphemism for “died by suicide”. The family and friends of suicide victims are often reluctant to openly discuss the cause of death because of profound sadness, sense of privacy, … Continue reading →

Limitation of access to lethal methods used for suicide—so-called means restriction—is an important population strategy for suicide prevention. Many empirical studies have shown that such means restriction is effective. Although some individuals might seek other methods, many do not; when … Continue reading →

Mental disorders are common in all countries, affect every community and age group, contribute substantially to the overall burden of disease, and have major economic and social consequences and effects on human rights. However, the greatest inequities are cross-national: 80% … Continue reading →

Emil Kraepelin’s demarcation between dementia praecox and manic depressive illness defined affective disorder as a remitting and recurring disease. He considered that only long-term outcome was useful in assessing accuracy of diagnosis and treatment response in patients.1 The more recent … Continue reading →

Quite reasonably, patients with bipolar disorder want treatment that provides sustained relief from their illness without incurring serious side-effects. Functionally, this translates to the resumption of purpose and enjoyment. But of the numerous drugs available for the management of bipolar … Continue reading →

Mental disorders are among the most common morbidities of pregnancy and the postnatal period, and can have adverse effects on the mother, her child, and family. This Series paper summarises the evidence about epidemiology, risk factors, identification, and interventions for … Continue reading →

Bipolar disorder is a clinically challenging condition. In addition to the multiple mood states that patients can experience, the illness is frequently associated with multiple comorbid medical and psychiatric conditions. Bipolar disorder can best be understood as a family of … Continue reading →